Beth E. Snitz, PhD

Associate Professor of Neurology

Title(s)

  • Associate Lead, Clinical Core, Alzheimer Disease Research Center

Biographical Sketch

Dr. Snitz is a neuropsychologist with research expertise in risk factors for dementia and cognitive decline in aging. She is involved in numerous clinical, neuroimaging and epidemiologic studies investigating cognitive aging across the normal and pathologic spectrum. As a PI, Dr. Snitz led an R01 examining PET neuroimaging biomarkers and longitudinal cognitive decline in a population-based sample of older adults without dementia. Research interests include cognitive correlates of biomarkers for Alzheimer disease and related disorders, subjective cognitive decline, and measurement issues in psychological assessment.

Education & Training

  • T-32 Post Doc, Department of Psychiatry, University of Pitt. fMRI
  • Post Doc Resident, Ruhr University Bochum, Germany, Medicine
  • Intern, Ann Arbor VAMC, Psychology
  • PhD, University of Minnesota -Twin Cities, Clinical Psychology
  • BA, Oberlin College, Biopsychology

Specialized Areas of Clinical, Research and/or Educational Interests 

  • Research: Early cognitive changes associated with preclinical and prodromal Alzheimer Disease; cognitive correlates of Alzheimer biomarkers; risk and protective factors for mild cognitive impairment and dementia; subjective cognitive decline.

Professional Organization Membership

  • American Psychological Association, Division 40, Society for Clinical Neuropsychology
  • International Neuropsychological Society
  • Editorial Board - Neurology
  • Editorial Board - Journal of the American Geriatrics Society
  • Scientific Advisory Committee - Society for Clinical Neuropsychology

Honors & Awards

  • NARSAD Young Investigator Award
  • NIH K-23 Career Development Award, National Institute on Aging

Selected Publications

Weinstein AM, Fang F, Chang CC, Cohen A, Lopresti BJ, Laymon CM, Nadkarni NK, Aizenstein HJ, Villemagne VL, Kamboh MI, Shaaban CE...& Snitz BE. Multimodal neuroimaging biomarkers and subtle cognitive decline in a population-based cohort without dementia. Journal of Alzheimer's disease: JAD. 2024 Dec 19;103(2):570. PMID: 39702989; PMCID: PMC11798718
 
Goldberg SM, Zhao Y, Cheng Y, Weinstein AM, Gujral S, Berman SB, Sweet RA, Butters MA, Lopez OL, & Snitz BE. Clinical progression of baseline risk states for Mild Cognitive Impairment. Journal of Alzheimer's disease: JAD. 2022;88(4):1377. PMID: 35786652; PMCID: PMC9661415
 
Snitz BE, Chang Y, Tudorascu DL, Lopez OL, Lopresti BJ, DeKosky ST, Carlson MC, Cohen AD, Kamboh MI, Aizenstein HJ, Klunk WE. & Kuller LH. Predicting resistance to amyloid-beta deposition and cognitive resilience in the oldest-old. Neurology. 2020 Aug 25;95(8):e984-94. PMID: 32699143; PMCID: PMC7668550 
 
Snitz BE, Wang T, Cloonan YK, Jacobsen E, Chang CH, Hughes TF, Kamboh MI, Ganguli M. Risk of progression from subjective cognitive decline to mild cognitive impairment: The role of study setting. Alzheimers Dement. 2018 Jun;14(6):734-742. doi: 10.1016/j.jalz.2017.12.003.  PMID: 29352855; PMCID: PMC5994356.
 
Zhao Y, Tudorascu DL, Lopez OL, Cohen AD, Mathis CA, Aizenstein HJ, Price JC, Kuller LH, Kamboh MI, DeKosky ST, Klunk WE, & Snitz BE. Amyloid β deposition and suspected non-Alzheimer pathophysiology and cognitive decline patterns for 12 Years in oldest old participants without dementia. JAMA Neurol. 2018 Jan 1;75(1):88-96. doi: 10.1001/jamaneurol.2017.3029. PMID: 29114732; PMCID: PMC5833487.